We are live on ! Find out more
PC

Polar Capital Portfolio holdings

AUM $13.5B
1-Year Est. Return 55.9%
This Fund
S&P 500
This Quarter Est. Return
+34.87%
1 Year Est. Return
+55.9%
3 Year Est. Return
+127.44%
5 Year Est. Return
+269.08%
10 Year Est. Return
–
AUM
$11.6B
AUM Growth
+$2.27B
Cap. Flow
-$278M
Cap. Flow %
-2.4%
Top 10 Hldgs %
30.23%
Holding
354
New
65
Increased
75
Reduced
125
Closed
74

Top Buys

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$106M
2
META icon
Meta Platforms (Facebook)
META
+$106M
3
PYPL icon
PayPal
PYPL
+$105M
4
XLNX
Xilinx Inc
XLNX
+$99.5M
5
CIEN icon
Ciena
CIEN
+$86.3M

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$85.6M
2
BMY icon
Bristol-Myers Squibb
BMY
+$84.6M
3
AMZN icon
Amazon
AMZN
+$72.7M
4
INTC icon
Intel
INTC
+$72.2M
5
RNG icon
RingCentral
RNG
+$71.8M

Sector Composition

Rank Sector Weight
1 Technology 36.14%
2 Healthcare 19.11%
3 Financials 17.15%
4 Communication Services 12.94%
5 Consumer Discretionary 7.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPLK
51
DELISTED
Splunk Inc
SPLK
$67.6M 0.58%
340,171
-130,410
-28% -$20.6M
AON icon
52
Aon
AON
$79.9B
$67.3M 0.58%
+349,500
New +$65.1M
WRB icon
53
W.R. Berkley
WRB
$28B
$65.9M 0.57%
2,587,500
-84,375
-3% -$2.07M
TER icon
54
Teradyne
TER
$53.1B
$64.8M 0.56%
+767,360
New +$51.4M
Y
55
DELISTED
Alleghany Corp
Y
$64.8M 0.56%
132,500
– –
LSCC icon
56
Lattice Semiconductor
LSCC
$16.3B
$64.3M 0.56%
2,264,912
-858,819
-27% -$20.1M
BMRN icon
57
BioMarin Pharmaceuticals
BMRN
$11.9B
$62.3M 0.54%
505,000
+305,000
+153% +$30.3M
IMMU
58
DELISTED
Immunomedics Inc
IMMU
$60.4M 0.52%
+1,703,340
New +$49.8M
INTC icon
59
Intel
INTC
$425B
$60.2M 0.52%
1,006,608
-1,208,180
-55% -$72.2M
IQV icon
60
IQVIA
IQV
$40.2B
$59.8M 0.52%
421,733
+71,333
+20% +$9.67M
HOLX
61
DELISTED
Hologic
HOLX
$59.4M 0.51%
+1,041,537
New +$51.1M
ANSS
62
DELISTED
Ansys
ANSS
$56.9M 0.49%
195,058
+38,359
+24% +$10.2M
QTNT
63
DELISTED
Quotient Limited Ordinary Shares
QTNT
$56.2M 0.49%
189,777
-489
-0.3% -$141K
POWI icon
64
Power Integrations
POWI
$3.18B
$55.3M 0.48%
936,590
+33,726
+4% +$1.77M
INCY icon
65
Incyte
INCY
$25.4B
$54.2M 0.47%
520,929
+22,069
+4% +$2.13M
SNPS icon
66
Synopsys
SNPS
$73.2B
$53.8M 0.46%
275,887
-97,739
-26% -$16.1M
FLIR
67
DELISTED
FLIR Systems, Inc. (DE) Common Stock
FLIR
$53.5M 0.46%
1,319,631
+264,163
+25% +$11M
HUBS icon
68
HubSpot
HUBS
$12.9B
$53.1M 0.46%
236,655
-42,567
-15% -$7.66M
DGX icon
69
Quest Diagnostics
DGX
$26B
$52.9M 0.46%
+464,029
New +$49.2M
COR icon
70
Cencora
COR
$62.2B
$51.4M 0.44%
+510,000
New +$47M
BHVN
71
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$51M 0.44%
697,038
-178,672
-20% -$9.51M
VRTX icon
72
Vertex Pharmaceuticals
VRTX
$124B
$49.7M 0.43%
171,337
+76,337
+80% +$20.7M
CGNX icon
73
Cognex
CGNX
$9.61B
$49.2M 0.43%
824,402
+40,520
+5% +$2.2M
EHTH icon
74
eHealth
EHTH
$42.2M
$49.2M 0.42%
500,671
+497,348
+14,967% +$57.8M
PGR icon
75
Progressive
PGR
$128B
$48.7M 0.42%
608,167
-66,833
-10% -$5.22M
1 2
3
4 5

Similar funds

ECM
ETrade Capital Management Arlington, Virginia $5.37B AUM 10.84% 1-Year Est. Return
FAAS
First Allied Advisory Services San Diego, California $2.98B AUM 15.89% 1-Year Est. Return
WAM
Wealthspire Advisors (Maryland) Potomac, Maryland $2.84B AUM 10.91% 1-Year Est. Return
FS
Feinberg Stephen $2.61B AUM 15.12% 1-Year Est. Return
NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return
TI
TT International London, United Kingdom $1.94B AUM
VIM
Veritas Investment Management London, United Kingdom $1.65B AUM 25.54% 1-Year Est. Return
PS
Peter Svennilson $1.23B AUM 301.34% 1-Year Est. Return

Polar Capital's Q2 2020 Portfolio in Review

As of Q2 2020, Polar Capital held 354 positions worth $11.6B, up 24% from $9.31B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Polar Capital's Q2 2020 filing shows 65 new, 75 increased, 125 reduced and 74 closed positions. Its largest new stake was TripAdvisor: 3,886,053 shares worth $73.9M. The largest sale was AbbVie, an estimated $85.6M.

By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 36% a quarter earlier, followed by Healthcare and Financials.

  • Polar Capital's largest Q2 2020 buy was TripAdvisor: 3,886,053 shares worth $73.9M.
  • Polar Capital added most to UnitedHealth in Q2 2020, an estimated $106M increase.
  • Polar Capital's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $84.6M.
  • Polar Capital fully exited AbbVie in Q2 2020, selling an estimated $85.6M.
  • Polar Capital's ten largest holdings make up 30% of its $11.6B portfolio in Q2 2020.
  • Polar Capital opened 65 new positions and closed 74 in Q2 2020.
  • Polar Capital's portfolio value rose 24% quarter-over-quarter to $11.6B.

Based on Polar Capital's 13F filing for Q2 2020, filed 14 Aug 2020.